The firm views the stock as fairly valued given its current risk/reward setup.
Following a period of underperformance relative to its peers, FMC's stock could be range bound. This is largely due to forecasts for a challenging 2016 in crop protection and high channel inventories in Brazil and North America.
Investors could see positive signs in 2017 but until then traders have enough time to see how the headwinds play out.
If fundamentals in Brazil and the U.S. improve, the urgency to buy into the name could happen sooner, according to the firm's note.
Shares closed Thursday's trading session up 2.81% to $41.31.
Based in Philadelphia, FMC is a global producer of crop protection chemicals (herbicides, insecticides,and fungicides), as well as functional food ingredients, pharmaceutical excipients, and lithium compounds.
Separately, TheStreet Ratings currently has a "Sell" rating on the stock with a letter grade of D+.
The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles' author.
You can view the full analysis from the report here: FMC